Form 4 for DNA Ginkgo Bioworks Holdings, Inc.
Accepted 2023-03-03 00:00:00 ET · period of report 2023-03-01 · accession 0001127602-23-008825 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-03 | 2023-03-01 | DNA | Dmytruk Mark E. | See remarks | M - OptEx | — | +1,635 | 495.2K | +0.3% | — |
| D | 2023-03-03 | 2023-03-01 | DNA | Dmytruk Mark E. | See remarks | M - OptEx | — | -1,635 | 650.0K | -0.3% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-03-01 | M | A | 1,635 | — | 495,217 | D | — | — | (F2) Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. |
| 2 | Derivative | Class B Common Stock | 2023-03-01 | M | D | 1,635 | — | 649,953 | D | — · — to — | 1,635 Class A Common Stock | (F2) Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. (F3) Includes shares of Class B Common Stock that are subject to vesting conditions. |